Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAINT: Bicarbonate and Buscopan for Labor Induction
NCT05719467Phase 3Recruiting
- Sponsor
- Oslo University Hospital
- Start
- Jan 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hyoscine butylbromide and sodium bicarbonate in labor induction (4 arms), sponsored by Oslo University Hospital. Primary endpoint: Spontaneous vs operative birth. Started Jan 2023; status: recruiting.
02
Drugs
hyoscine butylbromidesodium bicarbonate
03
Conditions
labor induction
Beyond the preview
Go deeper on NCT05719467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05719467.